Opportunity Information: Apply for RFA DA 20 006
The National Institutes of Health (NIH) funding opportunity titled "Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder" (Funding Opportunity Number RFA-DA-20-006) is a discretionary grant program using the R01 mechanism, with clinical trials explicitly not allowed. The central aim is to bring data science, computational, and quantitative expertise directly into addiction and substance use disorder research by encouraging investigators to develop and apply innovative methods that can combine and analyze complex datasets that are difficult to interpret using traditional approaches.
This opportunity is focused on "big data" approaches that integrate information across different data types and scales, with the idea that addiction biology and the neural mechanisms underlying substance use disorders can be better understood when diverse data streams are examined together rather than in isolation. The FOA emphasizes the creation or adaptation of novel computational, bioinformatics, statistical, and analytical strategies that enable new kinds of analyses. In practical terms, the program is looking for proposals where the primary contribution is methodological and integrative: approaches that can merge heterogeneous datasets, manage high dimensionality, uncover hidden structure or relationships, and generate insights that were previously inaccessible due to data complexity, fragmentation, or scale.
The expected outcome of funded projects is not merely the production of another dataset, but the development and demonstration of analytical frameworks that can reveal new aspects of addiction biology, especially neural mechanisms. That can include techniques for harmonizing or linking datasets collected at different resolutions (for example, molecular or genomic signals alongside neural circuit measures and behavioral or clinical phenotypes), building models that can account for multi-level influences, or designing computational pipelines that make it possible to test mechanistic hypotheses using integrated evidence. Although the FOA does not list specific required data modalities in the provided text, the intent is clearly to support work that leverages multi-source data integration and advanced analytics to push beyond conventional single-dataset or single-scale interpretations.
Eligibility is broad and spans many organizational types, which signals an interest in drawing talent from a wide range of sectors that include academia, government, nonprofits, and industry. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; small businesses; and other unspecified entities. The announcement also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). Taken together, this breadth suggests the FOA is designed to attract both domain experts and specialists in data-intensive methods, including teams that may not traditionally lead addiction neuroscience proposals but have strong computational capabilities.
From a logistics and administrative standpoint, the FOA falls under the Health and Education funding activity category and is associated with CFDA number 93.279. The opportunity was created on 2019-07-10, and the original closing date listed is 2019-11-14. An award ceiling is not specified in the provided source text, and the number of expected awards is also not provided, which typically means applicants would need to refer to the full NIH FOA document or related budget guidance for exact limits and expectations.
In summary, this R01 grant opportunity is essentially an invitation for data and computational scientists, as well as interdisciplinary teams, to build and apply next-generation analytic methods for integrating multi-type, multi-scale datasets in order to clarify the brain-based mechanisms of addiction and substance use disorder. The defining features are (1) methodological innovation in computation and analytics, (2) integration of diverse data sources to enable new analyses, (3) a focus on neural mechanisms and addiction biology, and (4) the clear restriction that proposed work must not include clinical trials.Apply for RFA DA 20 006
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2019-07-10.
- Applicants must submit their applications by 2019-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NRCS’ Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2020 – Pennsylvania
Previous opportunity: ONR, on behalf of the Office of the Secretary of Defense, for the Manufacturing Engineering Education Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 20 006
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 20 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed) Apply for RFA DA 20 007 Funding Number: RFA DA 20 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed) Apply for RFA DA 20 023 Funding Number: RFA DA 20 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for RFA CA 19 057 Funding Number: RFA CA 19 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) Apply for PAR 19 318 Funding Number: PAR 19 318 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Apply for RFA CA 19 045 Funding Number: RFA CA 19 045 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 19 046 Funding Number: RFA CA 19 046 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 19 325 Funding Number: PAR 19 325 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) Apply for PAR 19 320 Funding Number: PAR 19 320 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) Apply for PAR 19 326 Funding Number: PAR 19 326 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) Apply for PAR 19 321 Funding Number: PAR 19 321 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 19 327 Funding Number: PAR 19 327 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) Apply for RFA HL 20 016 Funding Number: RFA HL 20 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Apply for PAR 19 340 Funding Number: PAR 19 340 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 19 339 Funding Number: PAR 19 339 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 19 349 Funding Number: PAR 19 349 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 19 345 Funding Number: PAR 19 345 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 19 348 Funding Number: PAR 19 348 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 19 350 Funding Number: PAR 19 350 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 19 356 Funding Number: PAR 19 356 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 19 354 Funding Number: PAR 19 354 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 20 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
